Correction to: Nanocurcumin protects cardiomyoblasts H9c2 from hypoxia-induced hypertrophy and apoptosis by improving oxidative balance (Journal of Physiology and Biochemistry, (2015), 71, 2, (239-251), 10.1007/s13105-015-0405-0);Nanocurcumin protects cardiomyoblasts H9c2 from hypoxia-induced hypertrophy and apoptosis by improving oxidative balance

Journal of Physiology and Biochemistry

Volumn 71, Issue 2, 2015, Pages 239-251

  Nehra, Sarita ^a   Bhardwaj, Varun ^a   Kalra, Namita ^b   Ganju, Lilly ^a   Bansal, Anju ^a   Saxena, Shweta ^a   Saraswat, Deepika ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Apoptosis; Atrial natriuretic factor; Cardiomyoblast; Hypertrophy; Hypoxia; Nanocurcumin; Oxidative stress

Indexed keywords

CASPASE 3; CASPASE 7; CURCUMIN; NANOMATERIAL; PROTEIN; VASCULOTROPIN A;

ANIMAL; APOPTOSIS; CARDIAC MYOBLAST; CELL CULTURE; CELL HYPOXIA; CHEMISTRY; DRUG EFFECTS; HYPERTROPHY; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 7; CELL HYPOXIA; CELLS, CULTURED; CURCUMIN; HYPERTROPHY; MYOBLASTS, CARDIAC; NANOSTRUCTURES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84937761993     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-022-00886-5     Document Type: Erratum

References (38)

1. Akhtar F, Rizvi MMA, Kar SK (2012) Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Biotechnol Adv 30:310–320. doi:10.1016/j.biotechadv.2011.05.009
2. Anand P, Kunnumakkara AB, Newman RA et al (2007) Bioavailability of curcumin: problems and promises reviews bioavailability of curcumin problems and promises. Mol Pharm 4:807–818. doi:10.1021/mp700113r
3. Basnet P, Skalko-Basnet N (2011) Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16:4567–4598. doi:10.3390/molecules16064567
4. Bisht S, Feldmann G, Soni S et al (2007) Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J Nanobiotechnol 5:3. doi:10.1186/1477-3155-5-3
5. Cathcart R, Schwiers E, Ames BN (1983) Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal Biochem 134:111–116. doi:10.1016/0003-2697(83)90270-1
6. Chen Y, Wu Q, Zhang Z et al (2012) Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 17:5972–5987. doi:10.3390/molecules17055972
7. Choi H, Chun Y, Kim S et al (2006) Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol Pharmacol 70:1664–1671. doi:10.1124/mol.106.025817.
8. Filomeni G, Rotilio G, Ciriolo MR (2002) Cell signalling and the glutathione redox system. Biochem Pharmacol 64:1057–1064. doi:10.1016/S0006-2952(02)01176-0
9. Flora G, Gupta D, Tiwari A (2013) Nanocurcumin: a promising therapeutic advancement over native curcumin. Crit Rev Ther Drug Carrier Syst 30:331–368. doi:10.1615/CritRevTherDrugCarrierSyst.2013007236
10. Ghosh SS, Salloum FN, Abbate A et al (2010) Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats. Am J Physiol Heart Circ Physiol 299:H975–H984. doi:10.1152/ajpheart.00154.2010
11. Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Investig 115:500–5008. doi:10.1172/JCI200524408.500
12. Gupta S, Das B, Sen S (2007) Cardiac hypertrophy: mechanisms and therapeutic opportunities. Antioxid Redox Signal 9:623–652. doi:10.1089/ars.2007.1474
13. Gutteridge JM, Halliwell B (2000) Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 899:136–147. doi:10.1111/j.1749-6632.2000.tb06182.x
14. Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724. doi:10.1016/S0140-6736(94)92211-X
15. Haunstetter A, Izumo S (1998) Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 82:1111–1129. doi:10.1161/01.RES.82.11.1111
16. Hébert GANN, Pittman B, Mckinney RM (1981) Optimal fluorescein-to-protein ratios of bacterial direct fluorescent-antibody reagents. J Clin Microbiol 13:498–502
17. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214–226. doi:10.1016/0003-2697(76)90326-2
18. Hori M, Nishida K (2009) Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 81:457–464. doi:10.1093/cvr/cvn335
19. Hou J, Kang YJ (2012) Regression of pathological cardiac hypertrophy: Signaling pathways and therapeutic targets. Pharmacol Ther 135:337–354. doi:10.1016/j.pharmthera.2012.06.006
20. Jiang M, Zhang C, Wang J et al (2011) Adenosine A(2A)R modulates cardiovascular function by activating ERK1/2 signal in the rostral ventrolateral medulla of acute myocardial ischemic rats. Life Sci 89:182–187. doi:10.1016/j.lfs.2011.06.003
21. Kilic-eren M, Boylu T, Tabor V (2013) Targeting PI3K/Akt represses hypoxia inducible factor-1α activation and sensitizes Rhabdomyosarcoma and Ewing’s sarcoma cells for apoptosis. Cancel Cell Int 13:1–8
22. Kunwar A, Barik A, Mishra B et al (2008) Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochim Biophys Acta Gen Subj 1780:673–679. doi:10.1016/j.bbagen.2007.11.016
23. Møller P, Loft S, Lundby C, Olsen NV (2001) Acute hypoxia and hypoxic exercise induce DNA strand breaks and oxidative DNA damage in humans. FASEB J 15:1181–1186. doi:10.1096/fj.00-0703com
24. Nakamura K, Fushimi K, Kouchi H et al (1998) Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98:794–799. doi:10.1161/01.CIR.98.8.794
25. Nehra S, Bhardwaj V, Saraswat D (2014) Amlodipine protects rat ventricular cardiomyoblast H9c2 from hypoxia-induced apoptosis and restores oxidative balance by Akt-1-dependent manner. J Cardiovasc Pharmacol 64:375–384
26. Ruwhof C, van der Laarse A (2000) Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res 47:23–37
27. Sabbah HN (2000) Apoptotic cell death in heart failure. Cardiovasc Res 45:704–712
28. Schultz K, Fanburg BL, Beasley D et al (2006) Hypoxia and hypoxia-inducible factor-1alpha promote growth factor-induced proliferation of human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 02111:2528–2534. doi:10.1152/ajpheart.01077.2005
29. Seidl K, Zinkernagel AS (2013) The MTT assay is a rapid and reliable quantitative method to assess Staphylococcus aureus induced endothelial cell damage. J Microbiol Methods 92:307–309. doi:10.1016/j.mimet.2012.12.018
30. Selvetella G, Hirsch E, Notte A et al (2004) Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. Cardiovasc Res 63:373–380. doi:10.1016/j.cardiores.2004.04.031
31. Shehzad A, Ul-Islam M, Wahid F, Lee YS (2014) Multifunctional polymeric nanocurcumin for cancer therapy. J Nanosci Nanotechnol 14:803–814
32. Soonpaa MH, Field LJ, Soonpaa MH, Field LJ (1998) Point/counterpoint survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 83:15–26. doi:10.1161/01.RES.83.1.15
33. Stroka DM, Burkhardt T, Desbaillets I et al (2001) HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15:2445–2453. doi:10.1096/fj.01-0125com
34. Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49:241–248. doi:10.1161/01.HYP.0000254415.31362.a7
35. Tuttle S, Hertan L, Katz JS (2011) Indian gold treating cancer in the age of nano. Cancer Biol Ther 11:474–476. doi:10.4161/cbt.11.5.14810
36. Utley HG, Bernheim F, Hochstein P (1967) Effect of sulfhydryl reagents on peroxidation in microsomes. Arch Biochem Biophys 118:29–32. doi:10.1016/0003-9861(67)90273-1
37. Waterborg JH, Matthews HR (1984) The Lowry method for protein quantitation. Methods Mol Biol 1:1–3. doi:10.1007/978-1-60327-259-9
38. Watkins SJ, Borthwick GM, Arthur HM (2011) The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim 47:125–131. doi:10.1007/s11626-010-9368-1